2018 UEM Edgenta Annual Report

18. INVESTMENT IN ASSOCIATES (CONT’D.) (iii) Reconciliation of the summarised financial information presented above to the carrying amount of the Group’s interest in associates Faber Sindoori Biomedix One Medicare Sedafiat Total 2018 2017 2018 2017 2018 2017 2018 2017 2018 2017 RM’000 RM’000 RM’000 RM’000 RM’000 RM’000 RM’000 RM’000 RM’000 RM’000 Net assets at 1 January 31,989 19,367 22,247 7,501 26,573 24,181 34,493 24,585 115,302 75,634 Profit for the year 13,812 12,622 14,659 14,746 3,518 2,392 4,170 15,908 36,159 45,668 Dividend from associate – – (10,000) – – – (6,000) (6,000) (16,000) (6,000) Net assets at 31 December 45,801 31,989 26,906 22,247 30,091 26,573 32,663 34,493 135,461 115,302 Interest in associates 51% 51% 40% 40% 40% 40% 40% 40% Exchange differences (864) (716) – – – – – – (864) (716) Carrying value of Group’s interest in material associate 22,495 15,598 10,762 8,899 12,036 10,629 13,065 13,797 58,358 48,923 19. OTHER INVESTMENTS Group and Company 2018 2017 RM’000 RM’000 Equity instruments (unquoted shares in Malaysia) 1,200 1,200 Less: Accumulated impairment losses (1,200) (1,200) Unquoted shares, net – – Club memberships 272 272 272 272 20. INVENTORIES Group 2018 2017 RM’000 RM’000 Cost Consumables 11,397 11,691 Properties held for sale 145,381 157,010 156,778 168,701 During the year, the amounts of inventories recognised as expenses in cost of sales of the Group for consumables and properties held for sale were RM105.6 million and RM11.6 million (2017: RM93.3 million and RM4.4 million) respectively. NOTES TO THE FINANCIAL STATEMENTS For the year ended 31 December 2018 Management Discussion & Analysis UEM Edgenta Berhad Annual Report 2018 About UEM Edgenta Chairman’s Statement 208